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Introduction
Protein−protein1 and protein−nucleic acid2 interactions are 
central to cellular function and are also emerging targets for 
pharmacological intervention when implicated in a particular 
disease pathway. Thus numerous in vitro and in vivo methods 
have been developed to target3-7 and study these biomolecu-
lar interactions. Widely utilized in vitro methods for interrogat-
ing protein−protein and protein−DNA interactions and their 
antagonists include variations of enzyme linked immunosor-
bent assays (ELISAs), surface plasmon resonance (SPR), and 
fluorescence polarization (FP), which either require the use of 
antibodies or purified proteins and often require chemical de-
rivatization. On the other hand powerful in vivo methods such 
as yeast two-hybrid8 assays have the advantage of speed by 
eliminating the need for protein purification but can be subject 
to false positives and negatives due to the multifactorial nature 
of signal generation.9 In between these two extremes lie protein 
fragment based methods, where a specific biomolecular inter-
action drives the reassembly of a previously split reporter pro-
tein10 (Figure 1).
The reconstitution of a functional protein from split-pep-
tide fragments was first demonstrated for ribonuclease in 
1959.11 Since then “split-protein reassembly” or “protein com-
plementation” has been applied to the in vivo detection of a 
wide variety of protein−protein interactions utilizing numer-
ous split-proteins including ubiquitin,12 β-galactosidase,13 di-
hydrofolate reductase,14 β-lactamase,15 GFP,16 GFP-variants 
and analogues,17-19 firefly luciferase,20 and Gaussia lucifer-
ase.21 Recently, we and others have also described methods 
for detecting nucleic acids and their chemical modification by 
the reassembly of ternary complexes of split-GFP and split-β-
lactamase tethered to nucleic acid binding proteins.22-27 Thus 
split-protein systems or “protein complementation assays” 
(PCAs) can directly image most biomolecular interactions. Al-
though the current methods are of great utility, all of the cur-
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Abstract
Split-protein reporters have emerged as a powerful methodology for imaging biomolecular interactions which are of much interest as 
targets for chemical intervention. Herein we describe a systematic evaluation of split-proteins, specifically the green fluorescent protein, 
β-lactamase, and several luciferases, for their ability to function as reporters in completely cell-free systems to allow for the extremely 
rapid and sensitive determination of a wide range of biomolecular interactions without the requirement for laborious transfection, cell 
culture, or protein purification (12–48 h). We demonstrate that the cell-free split-luciferase system in particular is amenable for directly 
interrogating protein–protein, protein–DNA, and protein–RNA interactions in homogeneous assays with very high sensitivity (22–1800 
fold) starting from the corresponding mRNA or DNA. Importantly, we show that the cell-free system allows for the rapid (2 h) identi-
fication of target-site specificity for protein–nucleic acid interactions and in evaluating antagonists of protein–protein and protein–pep-
tide complexes circumventing protein purification bottlenecks. Moreover, we show that the cell-free split-protein system is adaptable for 
analysis of both protein–protein and protein–nucleic acid interactions in artificial cell systems comprising water-in-oil emulsions. Thus, 
this study provides a general and enabling methodology for the rapid interrogation of a wide variety of biomolecular interactions and 
their antagonists without the limitations imposed by current in vitro and in vivo approaches.
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rent split-protein methods have certain limitations for interro-
gating protein−protein and protein−nucleic acid interactions 
and their inhibitors in a very rapid and high-throughput fash-
ion. For example, current in vitro methods require extensive 
protein purification16, 27 and also rely on proper folding of re-
combinant proteins, while in vivo methods require lengthy 
transfection and propagation of cellular cultures prior to anal-
ysis, both approaches being time intensive.25, 28 The current 
methods are also prone to problems arising from potential 
proteolysis of intracellularly expressed proteins and peptides 
as well as a lack of control over interfering coexpressed cellu-
lar factors as is also the case with yeast n-hybrid methods.
To provide a rapid and general method that circumvents 
many of the limitations discussed above, we hypothesized that 
fragmented reporter proteins fused to functional proteins could 
be rapidly generated directly from mRNA utilizing cell-free 
translation methodologies and immediately interrogated for bio-
molecular interaction-dependent signal generation. The use of 
split-proteins in cell-free translation takes advantage of fast pro-
tein synthesis rates, from 60 to 90 min, and easy adaptation to 
homogeneous assays avoiding immobilization and washing 
protocols. Herein we demonstrate how this cell-free approach 
provides a general platform for rapidly detecting protein−pro-
tein, protein−small molecule, protein−DNA, protein-methylated 
DNA, and protein−RNA interactions starting from mRNA or di-
rectly from DNA corresponding to the desired interaction pair in 
less than 2 h. Moreover, we demonstrate how this approach aids 
in determining the specificity of protein−nucleic acid interactions 
as well as in determining small-molecule antagonists of protein−
protein interactions, which are currently of much interest.
Figure 1. Cell-free detection utilizing split-proteins. (a) Cartoon representation of a split-protein system with zinc fingers tethered to split-proteins 
in the presence of a target dsDNA oligonucleotide. Different split-protein reporters tethered to sequence specific zinc fingers in the presence and 
absence of target dsDNA; (b) split-Venus (a GFP variant), (c) split-β-lactamase, (d) split-firefly luciferase as described by Luker et. al,29 (e) split-
firefly luciferase as described by Paulmurugan et. al,30 and (f) split-Gaussia luciferase as described by Remy et. al.21
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Results and Discussion
Evaluation of Split-Protein Reporters for the Cell-Free In-
terrogation of Biomolecular Interactions. Initially, we eval-
uated the ability of our previously reported split-GFP23 and 
split-β-lactamase24, 27 systems appended to specific zinc fingers 
to reassemble in the presence of target DNA utilizing in vi-
tro transcribed mRNA in a purified wheat germ extract trans-
lation system (Figure 1b,c). Signal from the DNA-dependent 
reassembled GFP23 was too low to observe over background 
using standard fluorescence measurements, while DNA-de-
pendent β-lactamase activity27 yielded measurable but low 
signal-to-background ratios. Thus, we turned to recently re-
ported in vivo split-luciferase systems which have the signifi-
cant advantage of negligible background from the translation 
system due to the generation of a bioluminescent signal (Fig-
ure 1a). We chose to first examine the fragmented firefly lucif-
erase (Fluc) reported by Luker et. al29 which, when appended 
to our zinc fingers, showed significant signal over background 
luminescence upon addition of target DNA (Figure 1d). This 
comprises the first demonstration of the bioluminescent read-
out of a specific nucleic acid sequence, and accordingly this 
split-luciferase system was chosen for further studies in cell-
free systems. The very recently described split-Gaussia lucifer-
ase21 and alternatively split-firefly luciferase complementation 
systems29, 30 were also tethered to our zinc fingers and dis-
played extremely good signal over background biolumines-
cence (Figure 1e,f) in a DNA-dependent fashion and are cur-
rently being evaluated for their relative merits in a number of 
cell-free assays.
Detection of Protein−Protein and Protein−Nucleic Acid 
Interactions. To test the generality of the cell-free split-lucif-
erase approach we chose to investigate seven well-character-
ized and widely studied biomolecular interactions (Figure 2): 
(a) the catalytic subunit of cAMP-dependent protein kinase 
(PKA) with its inhibitor PKI (PKA/PKI)31-33 and (b) the ra-
pamycin-dependent interaction between the human FK506-
binding protein 12 (FKBP) and the FKBP12-rapamycin bind-
ing (FRB) domain of human mTOR (FKBP/FRB).34-36 Akin 
to the yeast three hybrid systems,37 we also investigated the 
ternary association of (c) two sequence-specific zinc fingers38 
with a target DNA (Zif268/PBSII), (d) a zinc finger and methyl 
CpG-binding domain with a target CpG-methylated DNA 
(Zif268/MBD2),39-42 and finally (e) two RNA-specific pumilio 
domains43 with a target RNA (Pum1/Pum2). Additionally the 
widely utilized coiled-coil domains of the transcription fac-
tors Fos and Jun (Fos/Jun)44-46 and the interaction between hy-
poxia inducible factor-1α (HIF-1α) and the CH1 domain of the 
transcriptional coactivator p300 (HIF-1α/p300)47, 48 were also 
tested (Supporting Information, Figure S1). The overall sensi-
tivity (signal/background) of these systems (Figure 2a−e) was 
excellent and varied from 22 to 1800-fold, while the total assay 
time from translation to analysis was less than 2 h.
We also investigated whether it was possible to directly 
couple transcription and translation in a cell-free lysate sys-
tem, which may eventually eliminate the need for the sepa-
rate in vitro transcription step that we are currently employ-
ing. (Figure 3). These experiments were likewise successful for 
both DNA and small-molecule dependent interactions (Figure 
3a,b). In addition to using purified lysate, we further interro-
gated whether we could detect the above interactions using 
a system composed entirely of purified translational compo-
nents49, 50 (Figure 3c,e), the so-called “PURE System,” thus 
demonstrating that reconstituted transcription and translation 
machinery is sufficient for detecting biomolecular interactions. 
This set of experiments clearly validates that a cell-free split-
luciferase assay format allows for the rapid, sensitive, and di-
rect detection of protein−protein, protein−small molecule, 
protein−DNA, protein-methylated DNA, and protein−RNA 
interactions starting from either mRNA or directly from DNA 
corresponding to the desired interaction pair. Having estab-
lished that our methodology provides robust signal for a wide 
variety of biomolecular interactions we turned to investigating 
whether this system is amenable to reporting upon inhibitors 
of protein−nucleic acid and protein−protein interactions.
Detecting Antagonists of Protein-Nucleic Acid Interac-
tions. In order to detect antagonists of protein−protein or pro-
tein−nucleic acid interactions, we first needed to demonstrate 
the thermodynamic reversibility of the ternary complex consist-
ing of reassembled firefly luciferase fragments tethered to two 
zinc fingers (PBSII and Zif268) and target DNA (Figure 4a). To-
ward this goal, translations using mRNA encoding PBSII-NFluc 
and CFluc-Zif268 were initiated in the presence of the target oli-
gonucleotide (Zif268-0-PBSII). Post DNA dependent firefly lu-
ciferase reassembly, a hairpin DNA (hpDNA-Zif268), which 
is a competitor for only Zif268 binding, was added at increas-
ing concentrations followed by equilibration for 30 min. A con-
centration dependent decrease in luminescence was observed, 
clearly demonstrating that the ternary complex of firefly lucifer-
ase and dsDNA was reversible and could be inhibited by addi-
tion of the dominant-negative (hpDNA-Zif268) oligonucleotide 
(Figure 4b, TGG containing hpDNA). The generality of utilizing 
the cell-free system for probing protein−nucleic acid inhibition 
was further demonstrated with translations containing mRNA 
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encoding Pum2-NFluc and CFluc-Pum1 in the presence of tar-
get RNA. As earlier, a concentration-dependent decrease in lu-
minescence was observed only upon the addition of increasing 
amounts of a competitor half-site RNA target that is known to 
selectively bind one of the pumilio domains43 (Figure 4e). Build-
ing on these results, we envisioned that our split-luciferase-
based cell-free system could be readily utilized to analyze the 
relative target site specificity of nucleic acid binding proteins 
through competitive binding experiments.
Identification of Protein−DNA Target-Site Specificity. A 
number of methods have been developed to interrogate the 
relative affinity of DNA-binding proteins for their target site, 
including traditional EMSAs and more recently DNA microar-





Figure 2. Cell-free detection of a wide variety of biomolecular interactions utilizing split-firefly luciferase starting from mRNA. Detection of (a) the 
protein−protein interaction between PKI-NFluc and CFluc-PKA; (b) the rapamycin-induced interaction between FRB-NFluc and CFluc-FKBP; (c) 
the protein−DNA interaction between PBSII-NFluc, CFluc-Zif268, and a target dsDNA oligonucleotide; (d) the methylation-dependent protein−
DNA interaction between MBD2-NFluc, CFluc-Zif268, and a target methylated CpG dsDNA oligonucleotide; and (e) the protein−RNA interaction 
between Pum2-NFluc, CFluc-Pum1, and a target RNA oligonucleotide.
51. Berger, M. F., Philippakis, A. A., Qureshi, A. M., He, F. S., Estep, P. 
W., and Bulyk, M. L. Nat. Biotechnol. 2006 24 1429–1435
52. Bulyk, M. L., Huang, X. H., Choo, Y., and Church, G. M. Proc. Natl. 
Acad. Sci. U.S.A. 2001 98 7158–7163
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of purified components, specialized equipment, or radioactive 
materials. Having established that ternary zinc finger−DNA 
complexes can be disrupted by a competitor oligonucleotide 
added in trans, we next attempted to correlate the known bind-
ing affinities of Zif268 for single-nucleotide changes in its bind-
ing site to IC50 values obtained from our cell-free firefly lucifer-
ase approach in a 96-well format. Separate translation reactions 
containing both PBSII-NFluc and CFluc-Zif268 mRNA in the 
presence of the dsDNA target oligonucleotide, Zif268-0-PBSII, 
were initiated. Duplicate experiments were allowed to translate 
and assemble for 90 min, forming ternary complexes, followed 
by the addition of increasing concentrations of a competitor hp-
DNA, containing one of four different Zif268 binding sites hav-
ing either A, T, C, or G at the central position. In each case a 
competitor hpDNA concentration-dependent decrease in lu-
minescence was observed (Figure 4b) within 30 min. IC50 val-
ues for each competitor hpDNA (Figure 4c) were shown to cor-
relate extremely well (R2 = 0.996) (Figure 4d) with previously 
reported relative affinities of these target sites.52 These results 
serve to validate the application of the split-luciferase cell-free 
system for the determination of relative binding affinities of nu-
cleic acid-binding proteins for their target sites and more gener-
ally in studying inhibitors of protein−nucleic acid interactions. 
Thus this cell-free system provides an attractive alternative to 
current methods for interrogating protein−nucleic acid bind-
ing specifities as it can be performed in a simple, rapid, high-
throughput, and homogeneous format without having to purify 
or refold the protein(s) of interest.
Detection of Small-Molecule and Peptide Modulators of 
Protein−Protein Interactions. Having demonstrated the ability 
to measure antagonists of protein−nucleic acid interactions, we 
next sought to interrogate the ability of cell-free firefly luciferase 
reassembly to report on antagonists and agonists of protein−
protein interactions. As a first test of small-molecule modula-
tion of split-luciferase activity we chose the well-characterized 
rapamycin-dependent interaction between the human FK506-
binding protein 12 (FKBP) and the FKBP12-rapamycin binding 
(FRB) domain of human mTOR (residues 2024−2113) 34 which 
has been a standard test for several split-protein reporter sys-
tems.21, 29, 30 A rapamycin concentration-dependent increase in 
luminescence was observed as expected from the cell-free trans-
lations of the split-reporters (Figure 5a).29
As our first test for antagonism of protein−protein interac-
tions, we chose the well-characterized interaction between the 
catalytic subunit of cAMP-dependent protein kinase (PKA) 
with its inhibitor PKI (residues 5−24).31 Initial experiments had 
demonstrated that the fusion proteins PKI-NFluc and CFluc-
PKA could be translated in vitro from mRNA and their associa-
Figure 3. Cell-free detection of biomolecular interactions with split-luciferase starting from DNA utilizing a coupled transcription and transla-
tion cell-free lysate system: (a) the protein−DNA interaction between PBSII-NFluc, CFluc-Zif268, and 5 nM target dsDNA oligonucleotides and (b) 
the rapamycin-induced (5 nM) interaction between FRB-NFluc and CFluc-FKBP. Detection of biomolecular interactions utilizing purified DNA in 
the PURESYSTEM classic II system consisting of completely purified transcriptional and translational components: (c) the protein−DNA interac-
tion between PBSII-NFluc, CFluc-Zif268, and 5nM target dsDNA oligonucleotide and (d) the rapamycin-induced (5 nM) interaction between FRB-
NFluc and CFluc-FKBP.
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tion monitored via luminescence (Figure 2a). Knowing that the 
reassembly of fragmented firefly luciferase is dependent upon 
PKA/PKI complex formation, the inhibition of this interac-
tion was interrogated by the addition of increasing concentra-
tions of a PKI peptide46 yielding an observed IC50 value of 11 
nM (Figure 5b). As a further example of the generality of this 
cell-free format, we interrogated the inhibition of an emerging 
anticancer target, specifically the interaction between hypoxia 
inducible factor-1α (HIF-1α) and the CH1 domain of the tran-
scriptional coactivator p300.53 Initial experiments (Support-
ing Information, Figure S1) demonstrated that the fusion pro-
teins p300-NFluc and CFluc-HIF-1α could be translated in vitro 
Figure 4. Interrogation of protein−nucleic acid interactions utilizing a split-firefly luciferase cell-free assay. (a) Cartoon showing the dissociation 
of the reassembled dsDNA−firefly luciferase ternary complex by the addition of a competitor hairpin DNA containing one of the two zinc finger 
binding sites. (b) Dissociation of the reassembled PBSII-NFluc, CFluc-Zif268, and dsDNA ternary complex by the addition of Zif268 hairpin DNA 
targets containing TGG (wild type, middle finger), TAG, TTG, and TCG triplet base pairs. (c) Previously reported relative affinities49 of target oli-
gonucleotides with Zif268 with IC50 values derived from the cell-free firefly luciferase reassembly assay and their correlation (d). (e) Dissociation 
of the Pum2-NFluc, CFluc-Pum1, and RNA ternary complex by the addition of an RNA target containing a Pum1 binding site.
Figure 5. Interrogation of small-molecule and peptide modulators of protein−protein interactions utilizing the split-firefly luciferase cell-free as-
say. (a) Concentration-dependent association of FRB-NFluc and CFluc-FKBP mediated by rapamycin (inset). (b) Concentration-dependent disso-
ciation of the PKI-NFluc/CFluc-PKA complex by PKI peptide. (c) Concentration-dependent dissociation of the reassembled p300-NFluc/CFluc-
Hif1α complex by chetomin (inset).
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from mRNA and their association monitored via luminescence. 
Recently, the small molecule chetomin has been identified as 
a first-in-class inhibitor of the interaction between HIF-1α and 
p300.48 To evaluate if our method could aid in the identifica-
tion of small-molecule inhibitors, mRNA encoding p300-NFluc 
and CFluc-HIF-1α fusion proteins were translated followed by 
the addition of increasing concentrations of the small molecule 
chetomin postreassembly. Luminescence measurements fol-
lowing chetomin incubation revealed a concentration depen-
dent decrease in signal and yielded an IC50 value of 290 nM 
(Figure 5c). Importantly, control experiments with excess chet-
omin or PKI-peptide showed no effect on signal generation in 
the zinc finger/DNA cell-free assay (Supporting Information, 
Figure S2), which verified that the loss in signal was dependent 
upon the disruption of specific protein−protein interactions 
rather than off-target effects such as inhibition of luciferase ac-
tivity. Thus, these three systems demonstrate that both peptide 
and small-molecule modulators of protein−protein interactions 
can be rapidly evaluated in the cell-free split-luciferase system 
without the need for transfection and cell-culture (current yeast 
n-hybrids and PCA methods), protein purification and selec-
tive fluorophore labeling (FP), or immobilization on solid sur-
faces (SPR and ELISA).
Application to Artificial Cell Systems. In addition to mon-
itoring protein−protein and protein−nucleic acid interactions, 
the cell-free methodology described here could potentially be 
used for the selection of protein−protein and protein−nucleic 
acid interactions. Elegant experiments by Tawfik and Griffiths 
have recently established that water-in-oil emulsions of in vi-
tro translation reactions can function as so-called artificial or 
“man-made” cells, which have been utilized for linking gen-
otype with phenotype in protein evolution experiments.54, 55 
Toward demonstrating that our cell-free split luciferase as-
say is compatible with in vitro compartmentalization, transla-
tions containing mRNA encoding PKI-NFluc and CFluc-PKA, 
or PBSII-NFluc, CFluc-Zif268 and target DNA were performed 
in wheat germ extract encapsulated in water-in-oil emulsions 
(Figure 6a), followed by luminescence analysis (Figure 6b,c). 
This set of experiments clearly demonstrates that the cell-
free split-firefly luciferase system has the potential for being 
adapted in screens for protein−protein and protein−nucleic 
acid interactions in artificial cell-based methodologies and 
may also find applications in studying proteins incorporating 
unnatural amino acids where significantly greater control over 
translational machinery components is often desirable.56-60
Conclusion
Numerous in vitro and in vivo methods are being developed 
to interrogate the interactions between proteins and nucleic ac-
ids, including strategies utilizing the reassembly of split-pro-
tein reporters. Although powerful, current cell-based and in 
vitro strategies depend on a number of cumbersome and time-
consuming steps including transfection, cell culture, purifica-
tion, washing steps, and/or covalent modification, yielding 
overall experimental times in excess of 12−48 h when starting 
from appropriate clones. Herein we have described a general 
platform for interrogating biomolecular interactions in homo-
geneous assays based on cell-free split-protein systems within 
2 h. This cell-free assay is capable of utilizing a variety of split-
protein reporters providing both fluorescent (β-lactamase) 
and bioluminescent (luciferase) signal outputs. One drawback 
of the current method as also found in ELISA and in vivo ap-
proaches is that only relative affinities and IC50 values can be 
determined, unlike with methods such as FP and SPR. How-
ever, the speed and ease of implementation of this cell-free 
approach, which does not require cell culture, protein purifi-
cation, or chemical derivatization, can be used to rapidly ad-
dress biological and chemical questions with appropriate con-
trols, as we have demonstrated with either dominant negative 
inhibition or a known small-molecule ligand.
Figure 6. Protein−protein and protein−DNA interactions in artificial cells interrogated by split-firefly luciferase-dependent bioluminescence. (a) 
White light microscope image of a water-in-oil emulsion containing a PKI-NFluc/CFluc-PKA translation in wheat germ extract. Scale bar is equal 
to 75 µm. (b) Protein−protein association (PKI-NFluc/CFluc-PKA)-dependent split-luciferase reassembly and bioluminescence within water-in-oil 
emulsion. (c) Protein−DNA interaction-dependent firefly luciferase reassembly within water-in-oil emulsion.
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Our experiments demonstrate the ability to detect a wide 
variety of protein−protein interactions, including the well-
studied heterodimerization of the leucine zippers Fos and 
Jun, the interaction between the protein kinase PKA and its 
inhibitor PKI, and the small-molecule-dependent interaction 
between FKBP and FRB. Additionally, we provide the first 
example of a rapid method for interrogating the interaction 
between HIF-1α and p300, an emerging protein−protein tar-
get implicated in cancer progression. Furthermore, we detail 
the first examples of sensitive split-luciferase-mediated detec-
tion of a wide range of protein−nucleic acid interactions, in-
cluding zinc finger domains with specific dsDNA, a methyl 
CpG-binding domain with specific methylated DNA, and 
RNA binding pumilio domains with target RNA. We have 
also demonstrated that this methodology can be utilized to 
interrogate the relative binding affinities of nucleic acid bind-
ing proteins for their target sites and the evaluation of small-
molecule and peptide modulators of protein−protein inter-
actions. In addition to using purified lysate and wheat germ 
extract, we have demonstrated the detection of protein−pro-
tein and protein−nucleic acid interactions using a system 
composed entirely of purified components that minimizes 
nonspecific interactions from cellular components and allows 
control over the translational machinery. This may find utility 
in numerous applications involving unnatural amino acid in-
corporation.56-60 Finally, we have demonstrated that the split-
protein reporters are functional in water-in-oil emulsions, 
providing artificial cell systems for studying protein−protein 
and protein−nucleic acid interactions that can potentially be 
utilized in screening methodologies.54
We envision that this cell-free format could potentially be 
used in a wide-variety of applications that include screening 
of DNA or RNA target sites for nucleic acid binding proteins 
and the determination of target site preference. More impor-
tantly perhaps, this approach can be used for screening small 
molecules, nucleic acids, peptides, or proteins for inhibition 
of specific protein−protein or protein−nucleic acid interac-
tions.1, 2 Moreover, since split-protein approaches have been 
widely utilized in a cellular context, the initial hits from the 
rapid cell-free system can be rapidly tested in a cellular con-
text.10, 20 Thus, we anticipate that this rapid, sensitive, and 
homogeneous assay system will be widely utilized for inter-
rogating user-defined natural and unnatural biomolecular 
interactions and for evaluating agonists and antagonists of 
these interactions.
Materials and Methods
General Materials. All materials were obtained from 
Sigma-Aldrich unless otherwise noted. ZnCl2 was obtained 
from EM Sciences. Restriction enzymes were obtained from 
NEB and in vitro translational products from Promega. Oligo-
nucleotide primers and targets were from IDT.
Plasmid Construction and mRNA Production. The fusion 
protein constructs used in this study are shown in Supporting 
Information, Table S1. DNA coding for N-terminal and C-ter-
minal reporter protein fragments (GFP, β-lactamase, and three 
luciferases) were generated by PCR with appropriate prim-
ers and subsequently cloned into either the pETDuet-1 vec-
tor (Novagen) or the pMAL-c2x vector (NEB) using standard 
techniques with verification by dideoxyoligonucleotide se-
quencing. Fragments encoding the nucleic acid-binding or as-
sociating proteins used in this study were generated by PCR 
starting from specific plasmids. The fusion protein constructs 
were generated using standard cloning techniques and veri-
fied by dideoxyoligonucleotide sequencing. The mRNA neces-
sary for cell-free assays was generated as follows: PCR frag-
ments corresponding to the desired fusion constructs were 
generated using a forward primer containing a T7 RNA poly-
merase promoter and a Kozak sequence and a reverse primer 
containing a 3′ hairpin loop. The purified PCR products were 
subsequently used as templates for in vitro transcription using 
the RiboMAX Large Scale RNA Production System-T7 (Pro-
mega) following the manufacturer’s protocols.
Target DNA Preparation. All nucleic acid targets were ob-
tained from IDT. A dsDNA target containing a zero base pair 
separation between the Zif268 and PBSII zinc finger sites (Z0P) 
was annealed as previously described.23 Hairpin DNA targets 
were annealed in 1x BamHI buffer by heating at 95 °C for 7 
min followed immediately by cooling on ice.
Reassembly of the GFP Variant Venus. Duplicate 150 µL 
translations were carried out in Wheat Germ Plus extract (Pro-
mega) according to the manufacturer’s protocol using 4 pmol 
of each mRNA encoding for NVenus(residues 1−157)-Zif268 
and PBSII-CVenus(residues 158−238), 10 µM ZnCl2, 0.5 µL of 
RNasin Plus (Promega), and either 50 nM Z0P target DNA or 
no DNA. Translations were incubated at 25 °C for 2 h (after 
which no fluorescence was observed) followed by interroga-
tion for fluorescence after a 20 h incubation at 4 °C. Fluores-
cence spectra were acquired by exciting at 515 nm and moni-
toring emission at 528 nm.
Reassembly of Split β-Lactamase-Zinc Finger Fusions. 
Four duplicate 25 µL translations were carried out in Wheat 
Germ Plus extract (Promega) according to the manufactur-
er’s protocol using 0.5 pmol of each mRNA encoding for 
NβLac(residues 26−196)-Zif268 and PBSII-CβLac(residues 
198−290), 10 µM ZnCl2, 0.5 µL of RNasin Plus (Promega), 
and either 20 nM Z0P target DNA or no DNA. Translations 
were incubated at 25 °C for 2 h and assayed by combining 
25 µL of translation solution to 75 µL of PBS buffer contain-
ing a final concentration of 10 µM Fluorocilin Green soluble 
β-lactamase substrate (Invitrogen). The final concentration of 
DNA in the assay was 5 nM. The rate of Fluorocillin Green 
hydrolysis was determined by exciting at 495 nm and moni-
toring emission at 525 nm with a 515 nm emission cutoff us-
ing a Spectra Max Gemini plate reader. Emission was read 
every 30 s for 10 min.
Reassembly of Split-Firefly Luciferase. Duplicate 25 
µL translations were carried out in Flexi-Rabbit Reticulo-
cyte Lysate (Promega) according to the manufacturer’s pro-
tocol using 2 pmol of each mRNA encoding for either PBSII-
NFluc(residues 2−416) and CFluc(residues 398−550)-Zif268 
or NFluc(residues 2−398)-Zif268 and PBSII-CFluc(residues 
394−550), 10 µM ZnCl2, 0.5 µL of RNasin Plus (Promega), and 
either 25 nM Z0P target DNA or no DNA. Translations were 
incubated at 30 °C for 90 min and assayed by combining 20 
µL of translation solution with 80 µL of Steady-Glo Luciferase 
Assay System (Promega). The final concentration of DNA in 
the assay was 5 nM. Light emission was monitored 1 min after 
Steady-Glo addition using a Turner TD-20e luminometer with 
a 3 s delay and a 10 s integration time.
Reassembly of Gaussia Luciferase. Duplicate 25 µL trans-
lations were carried out in Flexi-Rabbit Reticulocyte Lysate 
(Promega) according to the manufacturer’s protocol using 2 
pmol of each mRNA encoding for NGluc(residues 17−109)-
Zif268 and PBSII-CGluc(residues 110−185), 1 µM ZnCl2, 0.5 µL 
of RNasin Plus (Promega), and either 50 nM Z0P target DNA 
or no DNA. Translations were incubated at 30 °C for 90 min 
and assayed by combining 20 µL of translation solution with 
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80 µL of PBS buffer containing a final concentration of 20 µM 
coelenterazine. The final concentration of DNA in the assay 
was 5 nM. Light emission was monitored 10 min after coelen-
terazine addition using a Turner TD-20e luminometer with a 3 
s delay and a 10 s integration time.
Protein−Protein Interaction-Dependent Reassembly of 
Firefly Luciferase. Duplicate 25 µL translations were carried 
out in Flexi-Rabbit Reticulocyte Lysate (Promega) according 
to the manufacturer’s protocol using 2 pmol of each mRNA 
encoding the fusion proteins being analyzed, and 0.5 µL of 
RNasin Plus (Promega). Translations were incubated at 30 °C 
for 90 min and assayed by combining 20 µL of translation so-
lution to 80 µL of Steady-Glo Luciferase Assay System (Pro-
mega). For the rapamycin-induced interaction between FRB 
and FKBP either 5 nM rapamycin or control (DMSO) was 
added after translation followed by a 30 min incubation at 
room temperature. Light emission was monitored 1 min af-
ter Steady-Glo addition using a Turner TD-20e luminometer 
with a 3 s delay and a 10 s integration time.
Reassembly of Split-Firefly Luciferase in a Coupled 
Transcription/Translation System. Coupled transcription/
translation reactions were carried out in TNT T7 Coupled 
Rabbit Reticulocyte Lysate (Promega) according to the manu-
facturer’s protocol. Coupled reactions using split-firefly lucif-
erase−zinc finger fusions contained 0.5 pmols of each DNA 
encoding PBSII-NFluc and CFluc-Zif268, 10 µM ZnCl2, 1 µL 
of RNasin Plus (Promega), and either 100 nM Z0P target 
DNA or no DNA in a total of 25 µL. Coupled reactions us-
ing split-firefly luciferase−FKBP and FRBP fusions contained 
0.5 pmol of DNA encoding FRB-NFluc and CFluc-FKBP, and 
1 µL of RNasin Plus (Promega) in a total of 25 µL. Solutions 
were incubated at 30 °C for 90 min. Reactions were diluted at 
a 1:4 ratio into PBS buffer containing 1% BSA (1% BSA and 
either 25 nM rapamycin or DMSO in the case of FRB/FKBP) 
and equilibrated at room temperature for 30 min. Samples 
were assayed for luciferase activity by combining 20 µL of 
translation solution with 80 µL of Steady-Glo Luciferase As-
say System (Promega). Luminescence readings were taken 
on a Turner TD20e luminometer using a 3 s delay and a 10 
s integration; the average of replicate experiments is shown. 
The final concentration of Z0P or rapamycin in the assay was 
5 nM.
Reassembly of Split-Firefly Luciferase in a Purified 
Transcription/Translation System. Coupled transcription/
translation reactions were carried out using the PURESYS-
TEM classic II system (Post Genome Inst. Co. Ltd.) accord-
ing to the manufacturer’s protocol. Coupled reactions using 
split-firefly luciferase-zinc finger fusions contained 0.5 pmols 
of each DNA encoding PBSII-NFluc and CFluc-Zif268, 10 µM 
ZnCl2, 1 µL of RNasin Plus (Promega), and either 100 nM 
Z0P target DNA or no DNA in a total of 25 µL. Coupled re-
actions using split-firefly luciferase-FKBP and FRBP fusions 
contained 0.5 pmol of DNA encoding FRB-NFluc and CFluc-
FKBP, and 1 µL of RNasin Plus (Promega) in a total of 25 µL. 
Solutions were incubated at 37 °C for 60 min, followed by the 
addition of either 25 nM rapamycin or vehicle in the case of 
FKBP/FRB. Samples were assayed for luciferase activity by 
combining 20 µL of translation solution with 80 µL of Steady-
Glo Luciferase Assay System (Promega). Luminescence read-
ings were taken on a Turner TD20e luminometer using a 3 s 
delay and 10 s integrations, the average of replicate experi-
ments is shown. The final concentration of Z0P or rapamycin 
in the assay was 5 nM.
Competition Assay to Identify Protein−DNA Target Site 
Specificity. Duplicate 25 µL translations were carried out in 
Flexi-Rabbit Reticulocyte Lysate (Promega) according to the 
manufacturer’s protocol using 0.05 pmol of mRNA encoding 
PBSII-NFluc and CFluc-Zif268, 10 µM ZnCl2, and 0.5 µL of 
RNasin Plus (Promega) and allowed to incubate for 90 min at 
30 °C in the presence of 750 pM Z0P dsDNA target. Follow-
ing translation and firefly luciferase reassembly, increasing 
concentrations of each Zif268 hairpin DNA being tested were 
added followed by a 30 min incubation at room temperature. 
Samples were assayed for luciferase activity by combining 20 
µL of translation solution with 80 µL of Steady-Glo Lucifer-
ase Assay System (Promega). Light emission was monitored 
1 min after Steady-Glo addition using a Wallac 1420 VICTOR 
3 V luminometer with a 1 s integration time.
Dissociation of the Reassembled Pum2-NFluc, CFluc-
Pum1, RNA Ternary Complex. Duplicate 25 µL translation 
reactions were carried out in Rabbit Reticulocyte Lysate (Pro-
mega) according to the manufacturer’s protocol using 0.1 
pmol of mRNA encoding Pum2-NFluc and CFluc-Pum1 and 
0.5 µL of RNasin Plus (Promega) and allowed to incubate for 
90 min at 30 °C in the presence of 2.5 nM RNA oligonucle-
otide target. Following translation and firefly luciferase reas-
sembly, increasing concentrations of a competitor RNA oli-
gonucleotide were added followed by a 30 min incubation 
at room temperature. Samples were assayed for luciferase 
activity by combining 20 µL of translation solution with 80 
µL of Steady-Glo Luciferase Assay System (Promega). Light 
emission was monitored 1 min after Steady-Glo addition us-
ing a Turner TD-20e luminometer with a 3 s delay and a 10 s 
integration time.
Detection of Small-Molecule and Peptide Modulators 
of Protein−Protein Interactions. Duplicate 25 µL transla-
tion reactions were carried out in Rabbit Reticulocyte Lysate 
(Promega) according to the manufacturer’s protocol using 
2 pmols of mRNA encoding either FRB-NFluc and CFluc-
FKBP, PKI-NFluc and CFluc-PKA, or p300-NFluc and CFluc-
HIF-1α and 0.5 µL of RNasin Plus (Promega) and allowed to 
incubate for 90 min at 30 °C. For analysis of the p300/HIF-1α 
interaction 10 µM ZnCl2 was added to the translation reac-
tion. Following translation, lysates were diluted 1:4 with PBS 
containing 1% BSA followed by the addition of increasing 
concentrations of either rapamycin in DMSO, PKI, or chet-
omin in DMSO followed by a 30 min incubation at room tem-
perature. Samples were assayed for luciferase activity by 
combining 20 µL of translation solution with 80 µL of Steady-
Glo Luciferase Assay System (Promega). Light emission was 
monitored 1 min after Steady-Glo addition using a Wallac 
1420 VICTOR 3 V luminometer with a 1 s integration time.
Reassembly of Split-Firefly Luciferase in Water-in-Oil 
Emulsions. Water-in-oil emulsions were prepared in 2 mL 
round-bottom cryogenic vials by adding 50 µL of aqueous 
phase, over 2 min, into 950 µL of mineral oil containing 4.5% 
Span 80 and 0.5% Tween 80 while stirring at 1150 rpm using a 
2 mm × 9 mm stir bar. Stirring was continued for one minute 
after the complete addition of the aqueous phase. Translations 
were prepared on ice using Wheat Germ Plus extract (Pro-
mega) according to the manufacturer’s protocol using 4 pmol 
of each mRNA encoding either PKI-NFluc, CFluc-PKA, or 
both and 0.5 µL of RNasin Plus (Promega). For DNA-depen-
dent reassembly, 4 pmol of each mRNA encoding for CFluc-
Zif268 and PBSII-NFluc, 10 µM ZnCl2, 0.5 µL of RNasin Plus 
(Promega), and either 25 nM Z0P target DNA or no DNA were 
mixed in a total of 50 µL. Emulsions were prepared using the 
ice-cold translation as the aqueous phase. Emulsions were in-
cubated at 25 °C for 2 h and assayed by combining 20 µL of 
emulsion with 80 µL of Steady-Glo (Promega). Luminescence 
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readings were taken on a Turner TD20e luminometer using a 3 
s delay and a 10 s integration time.
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Supplementary Figure S1.  Detection of Fos/Jun and p300/HIF-1α interactions. (a) 
Association dependent firefly luciferase reassembly of Fos-NFluc and CFluc-Jun fusions 
utilizing in vitro transcribed mRNA in a rabbit reticulocyte lysate translation system.  A 
significant signal increase is observed when Fos-NFluc and CFluc-Jun are co-expressed 
over either fusion protein alone. (b) Association dependent firefly luciferase reassembly 
of p300-NFluc and CFluc-HIF-1α fusions utilizing in vitro transcribed mRNA in a rabbit 
reticulocyte lysate translation system.  A significant signal increase is observed when 








Supplementary Figure S2. Interrogating off target effects of the PKI (peptide) and 
chetomin  (small molecule) protein-protein interaction inhibitors on the DNA dependent 
firefly luciferase reassembly system (ternary complex: PBSII-NFluc, CFluc-Zif268, and 
5nM target dsDNA oligonucleotide).  No decrease in signal is observed upon addition of 

























Supplementary Table S1. Z0P dsDNA Target (5’-GCGTAGCGTGGGCGGTGTGGAA 




Fos/Jun and p300/HIF-1α association dependent reassembly of firefly luciferase.   
Duplicate 25 µL translations were carried out in Flexi-Rabbit Reticulocyte Lysate 
(Promega) according to the manufacturer’s protocol using 2 pmol of each mRNA 
encoding for either Fos-NFluc, CFluc-Jun, or both, and 0.5 µL of RNasin Plus 
(Promega).  Translations were incubated at 30 oC for 90 minutes and assayed by 
combining 20 µL of translation solution with 80 µL of Steady-Glo Luciferase System 
(Promega).  Light emission was monitored using a Turner TD-20e luminometer with a 3 
second delay and a 10 second integration time. 
 
Duplicate 25 µL translations were carried out in Flexi-Rabbit Reticulocyte Lysate 
(Promega) according to the manufacturer’s protocol using 2 pmol of each mRNA 
encoding for either p300-NFluc, CFluc-HIF-1α, or both, 10 µM ZnCl2 and 0.5 µL of 
RNasin Plus (Promega).  Translations were incubated at 30 oC for 90 minutes and 
assayed by combining 20 µL of translation solution with 80 µL of Steady-Glo Luciferase 
System (Promega).  Light emission was monitored using a Turner TD-20e luminometer 
with a 3 second delay and a 10 second integration time. 
 
Determination of off target effects of PKI and chetomin on signal generation.  
Duplicate 25 µL translations were carried out in Flexi-Rabbit Reticulocyte Lysate 
(Promega) according to the manufacturer’s protocol using 2 pmol of each mRNA 
encoding for PBSII-NFluc (residues 2-416) and CFluc-Zif268 (residues 398-550), 10 µM 
S4 
ZnCl2, 0.5 µL of RNasin Plus (Promega), and 25 nM Z0P target DNA (Table S1).  
Translations were incubated at 30 oC for 90 minutes followed by the addition of either 10 
µM PKI, 300 µM chetomin, or DMSO and allowed to incubate at room temperature for 
30 minutes.  Light emission was assayed by adding 20 µL of translation to 80 µL of 
Steady-Glo Luciferase Assay System (Promega).  Final concentrations in the assays were 
5 nM DNA, 5 nM DNA plus 100 nM PKI, and 5 nM DNA and 3 µM chetomin.  Light 
emission was monitored 1 minute after Steady-Glo addition using a Wallac 1420 
VICTOR 3™ V luminometer with a 1 second integration time. 
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